CRISPR
CRISPR/Cas9 Genome Editing
Conservative Site-specific Recombination and Phase Variation
CRISPR and crRNAs
Homologous Recombination
RNA Polymerase II Accessory Proteins
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 28, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
Published on: May 30, 2025
Meng Chen1,2, Lei Stanley Qi3,4,5
1Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system, when modified to a deactivated form (dCas9), enables precise gene activation. This CRISPR/dCas9 technology offers a powerful and scalable method for endogenous gene regulation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: